|
|
|
40
|
A061C
|
FLUDARABINE 50MG INJ (INP/AHI)
|
FLUDARABINE
|
FLUDARABINE
|
50MG VIAL
|
BQ
|
134.61
|
134.61
|
INJECTION
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
A061F
|
FLUDARABINE 50MG INJ (KWA)
|
FLUDARABINE
|
FLUDARABINE
|
50MG VIAL
|
BQ
|
626.93
|
626.93
|
VIAL
|
0
|
|
KWA
|
KWALITY PHARMACEUTICALS
|
STO
|
BRYDEN STOKES LTD
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
2026-03-02
|
|
|
|
40
|
A0811
|
PNEUMOVAX 23 INJ (MSD/STO) PNEUMOCOCCAL
|
STREPTOCOCCUS PNEUMONIA TYPES
|
PNEUMOVAX
|
0.5ML VIAL
|
C
|
23.98
|
23.98
|
INJECTION
|
0
|
VIAL
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
8012
|
VACCINES
|
2022-07-26
|
2024-03-31
|
Package Size Change
|
IM
|
|
SERUMS, TOXOIDS AND VACCINES
|
2022-07-26
|
|
|
|
41
|
A0811
|
PNEUMOVAX 23 INJ (MSD) PNEUMOCOCCAL
|
STREPTOCOCCUS PNEUMONIA TYPES
|
PNEUMOVAX
|
0.5ML VIAL
|
B
|
24.68
|
24.6824
|
VIAL
|
1
|
VIAL
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
8012
|
VACCINES
|
2024-04-01
|
2026-03-31
|
|
IM
|
0
|
VACCINES
|
|
|
|
|
40
|
A0814
|
PNEUMOVAX 23 25MCG INJ (MSD/STO) PNEUMOCOCCAL
|
PNEUMOCOCCAL
|
PNEUMOVAX 23
|
10X0.5ML
|
B
|
239.78
|
23.98
|
INJECTION
|
0
|
AMP
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
8012
|
VACCINES
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
SERUMS, TOXOIDS AND VACCINES
|
|
|
|
|
40
|
A0825
|
PREVNAR 13 16MCG INJ (PFI/STO) PNEUMOCOCCAL
|
STREPTOCOCCUS PNEUMONIA TYPES
|
PREVNAR 13
|
1 DOSE
|
B
|
176.23
|
176.23
|
INJECTION
|
0
|
VIAL
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
8012
|
VACCINES
|
2022-04-01
|
2022-06-21
|
|
IV
|
0
|
SERUMS, TOXOIDS AND VACCINES
|
|
|
|
|
40
|
A0825
|
PREVNAR 13 16MCG INJ (PFI/STO) PNEUMOCOCCAL
|
STREPTOCOCCUS PNEUMONIA TYPES
|
PREVNAR 13
|
1 DOSE
|
B
|
223.12
|
223.12
|
INJECTION
|
0
|
VIAL
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
8012
|
VACCINES
|
2022-06-22
|
2024-03-31
|
Price Change
|
IV
|
0
|
SERUMS, TOXOIDS AND VACCINES
|
2022-06-22
|
|
|
|
41
|
A0825
|
PREVNAR 13 16MCG INJ (PFI) PNEUMOCOCCAL
|
STREPTOCOCCUS PNEUMONIA TYPES
|
PREVNAR 13
|
1 DOSE
|
B
|
177.94
|
177.9415
|
VIAL
|
1
|
VIAL
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
8012
|
VACCINES
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
VACCINES
|
|
|
|
|
42
|
A0825
|
PREVNAR 13 16MCG INJ (PFI) STREPTOCOCCUS PNEUMONIA TYPES
|
STREPTOCOCCUS PNEUMONIA TYPES
|
PREVNAR 13
|
0.5ML PFS
|
B
|
177.94
|
177.94
|
PFS
|
0
|
VIAL
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
8012
|
VACCINES
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
VACCINES
|
|
|
|
|
40
|
A101L
|
LABETALOL 5MG/ML INJ (MON/PHA)
|
LABETALOL
|
LABETALOL
|
20ML
|
B
|
8.67
|
8.67
|
INJECTION
|
0
|
VIAL
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
2424
|
BETA ADRENERGIC BLOCKING AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
42
|
A101L
|
LABETALOL 5MG/ML INJ (MON)
|
LABETALOL
|
LABETALOL
|
20ML
|
B
|
4.65
|
4.65
|
VIAL
|
0
|
VIAL
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
2424
|
BETA ADRENERGIC BLOCKING AGENTS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
BETA ADRENERGIC BLOCKING AGENTS
|
|
|
|
|
40
|
A101M
|
LABETALOL 5MG/ML INJ (KWA/ATB)
|
LABETALOL
|
LABETALOL
|
20ML AMP
|
B
|
4.05
|
4.05
|
INJECTION
|
0
|
AMP
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
2424
|
BETA ADRENERGIC BLOCKING AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
A101T
|
LABETALOL 5MG/ML INJ (LDP) (B)
|
LABETALOL
|
LABETALOL
|
20ML
|
B
|
7.09
|
7.0948
|
AMP
|
0
|
AMP
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
2424
|
BETA ADRENERGIC BLOCKING AGENTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
BETA ADRENERGIC BLOCKING AGENTS
|
|
|
|
|
41
|
A101U
|
LABETALOL 5MG/ML INJ (FSB) (B)
|
LABETALOL
|
LABETALOL
|
20ML VIAL
|
B
|
4.95
|
4.9473
|
VIAL
|
0
|
VIAL
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
2424
|
BETA ADRENERGIC BLOCKING AGENTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
BETA ADRENERGIC BLOCKING AGENTS
|
|
|
|
|
42
|
A101X
|
LABETALOL 5MG/ML INJ (FSB)
|
LABETALOL
|
LABETALOL
|
20ML VIAL
|
B
|
4.43
|
4.43
|
VIAL
|
0
|
|
FSB
|
FLAGSHIP BIOTECH
|
STO
|
BRYDEN STOKES LTD
|
|
2424
|
BETA ADRENERGIC BLOCKING AGENTS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
BETA ADRENERGIC BLOCKING AGENTS
|
2026-03-05
|
|
|
|
40
|
A1022
|
APO-LABETALOL 100MG TAB (APO/COL)
|
LABETALOL
|
APO-LABETALOL
|
100'S
|
A
|
54.37
|
0.54
|
TABLET
|
90
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
B
|
2424
|
BETA ADRENERGIC BLOCKING AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
42
|
A1022
|
APO-LABETALOL 100MG TAB (APO)
|
LABETALOL
|
APO-LABETALOL
|
100'S
|
A
|
55.45
|
0.55
|
TAB
|
90
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
B
|
2424
|
BETA ADRENERGIC BLOCKING AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
BETA ADRENERGIC BLOCKING AGENTS
|
|
|
|
|
40
|
A102D
|
LABETALOL 100MG TAB (LDP/AHI)
|
LABETALOL
|
LABETALOL
|
100'S
|
A
|
67.93
|
0.68
|
TABLET
|
90
|
TAB
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
2424
|
BETA ADRENERGIC BLOCKING AGENTS
|
2022-04-01
|
2022-09-30
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
2022-03-29
|
|
|
|
41
|
A102F
|
APO-LABETALOL 100MG TAB (APO)
|
LABETALOL
|
APO-LABETALOL
|
100'S
|
A
|
55.45
|
0.5545
|
TAB
|
90
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
2424
|
BETA ADRENERGIC BLOCKING AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
BETA ADRENERGIC BLOCKING AGENTS
|
|
|
|
|
42
|
A102L
|
LIBETOR 100MG TAB (JLP) LABETALOL
|
LABETALOL
|
LIBETOR
|
10X10
|
A
|
23.92
|
0.24
|
TAB
|
90
|
BLIS
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
2424
|
BETA ADRENERGIC BLOCKING AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
BETA ADRENERGIC BLOCKING AGENTS
|
|